PCGF6/MAX/KDM5D facilitates MAZ/CDK4 axis expression and pRCC progression by hypomethylation of the DNA promoter.

Zhu, Meng; Zhang, Ruo-Nan; Zhang, Hong; Qu, Chang-Bao; Zhang, Xiao-Chong; Ren, Li-Xin; Yang, Zhan; Gu, Jun-Fei

Zhu, Meng; Zhang, Ruo-Nan; Zhang, Hong; Qu, Chang-Bao; Zhang, Xiao-Chong; Ren, Li-Xin; Yang, Zhan; Gu, Jun-Fei.

Affiliation

Zhu M; Department of Urology, The Second Hospital of Hebei Medical University, 215 Heping West Road, Shijiazhuang, 050000, China.
Zhang RN; School of Chinese Integrative Medicine, Hebei Medical University, Shijiazhuang, Hebei, China.
Zhang H; Department of Urology, The Second Hospital of Hebei Medical University, 215 Heping West Road, Shijiazhuang, 050000, China.
Qu CB; Department of Urology, The Second Hospital of Hebei Medical University, 215 Heping West Road, Shijiazhuang, 050000, China.
Zhang XC; Clinical Laboratory, Xingtai People's Hospital, Xingtai, China.
Ren LX; Department of Urology, The Second Hospital of Hebei Medical University, 215 Heping West Road, Shijiazhuang, 050000, China.
Yang Z; Department of Urology, The Second Hospital of Hebei Medical University, 215 Heping West Road, Shijiazhuang, 050000, China.
Gu JF; Molecular Biology Laboratory, Talent and Academic Exchange Center, The Second Hospital of Hebei Medical University, Shijiazhang, China.

Epigenetics Chromatin ; 16(1): 9, 2023 03 09.

Article de En | MEDLINE | ID: mdl-36890610

Sujet(s)
Mots clés

Hypomethylation; Myc-related zinc finger protein; PCGF6; Papillary renal cell carcinoma

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Néphrocarcinome / Tumeurs du rein Limites: Humans Langue: En Journal: Epigenetics Chromatin Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google